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RESUMEN
Objetivos: Las especies de enterococos son intrínsecamente resistentes a varios antibióticos, adquieren 
resistencia con relativa facilidad, y difunden estos genes de resistencia a otras especies. La resistencia a 
los antibióticos en enterococos está asociada al uso de los mismos en la clínica médica y también a la di-
seminación de clones resistentes en el mundo. El objetivo de este trabajo fue comparar las características 
de las cepas de enterococos resistentes a vancomicina (ERV) aisladas en efluentes hospitalarios y aguas 
residuales urbanas.
Métodos: Se obtuvieron muestras de los efluentes del Hospital Universitario José de San Martín (Buenos 
Aires) y muestras de aguas residuales urbanas de la ciudad de Buenos Aires.
Resultados: Los recuentos de ERV fueron mayores en los efluentes hospitalarios, siendo la odds ratio 
36.4 (IC95%: 26.0-50.8; p<0.0001). Los ERV aislados se identificaron principalmente como E. faecium. Los 
resultados indicaron una alta prevalencia de enterococos resistentes al resto de los antibióticos ensaya-
dos.
Conclusión: Podemos concluir que los efluentes de los centros hospitalarios constituyen una fuente de 
enterococos de resistencia múltiple a antibióticos.
Palabras clave: enterococos resistentes a vancomicina; multirresistencia; efluente hospitalario; antibióti-
cos; aguas residuales urbanas.
ABSTRACT
Objectives: Enterococci are intrinsically resistant to many commonly used antimicrobial agents. They 
are able to acquire resistance with relative ease and can spread these genes to other species. Enterococci 
resistant to antibiotics are associated with the use of these in clinical practice and also the spread of 
resistant clones in the world. The aim of this work was to compare the characteristics of the strains of 
vancomycin-resistant enterococci (VRE) isolated from municipal wastewater and hospital effluent.
Methods: Samples were obtained from the effluent of the Hospital Universitario José de San Martín 
(Buenos Aires) and the municipal wastewater of the city of Buenos Aires.
Results: The bacterial counts of VRE were greater in the hospital effluent, with an odds ratio of 36.4 (95% 
CI: 26.0-50.8; p<0.0001). The VRE isolated were mainly identified as E. faecium. The results indicate a high 
prevalence of enterococci resistant to the antibiotics tested.
Conclusion: We may conclude that the effluents of hospitals constitute a source of VRE showing multi-
ple resistance to antibiotics.
Keywords: vancomycin-resistant enterococci; multi-resistance; hospital effluent; antibiotics; municipal 
wastewater.
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INTRODUCTION
Water bodies receive urban wastewater, often inadequately 
treated, with serious consequences for public health and 
the environment. Untreated urban sewage contains a high 
concentration of organic matter and an abundance of path-
ogenic and saprophytic microorganisms. The water bodies 
are inherently capable of self-purification, but at times the 
influx of contaminants exceeds this capacity.
Enterococci, which are part of the natural intestinal flora 
of animals and humans, can be released to the environ-
ment by means of sewage or wastewater.11 Some members 
of the genus, such as Enterococcus faecalis and Enterococcus 
faecium, are opportunist pathogens.13 One factor contribut-
ing to the pathogenesis of enterococci is their resistance to 
a broad range of antibiotics. This resistance has increased 
in recent years.16 Vancomycin is a glycopeptide antibiotic 
used for serious infections by Gram-positive bacteria when 
treatment with other antibiotics has failed. The excessive 
use of this antimicrobial agent has led to the appearance 
of vancomycin-resistant enterococci (VRE), most notably E. 
faecalis and E.faecium.4
The epidemiology of infection by enterococci resistant to 
glycopeptides differs markedly between Europe and the 
United States. In Europe VRE are frequently isolated from 
farm animals, associated with a widespread use, until 1997, 
of avoparcin by bird breeders to promote growth.4 In the 
United States, avoparcin was never approved for use in 
breeding animals, for which reason VRE are not found in 
animals or healthy people. However, nosocomial infection 
by VRE has undergone a dramatic increase attributed to 
the generalized use of vancomycin in hospitals.25 In Latin 
America, the rate of VRE from clinical isolation increased 
from 5% to 15% between 2003 and 2008; the most signifi-
cant increase was seen in Brazil, with figures of VRE that 
increased from 7% to 31% in the same time period.24
Human activities and especially those related with the use 
of antibiotics when breeding fowl and fish, and in human 
and veterinary medicine, may be at the root of the high in-
cidence of resistance detected in microorganisms isolated 
from the environment.2,18 Hospitals represent critical en-
vironments for the selection of clinically relevant bacterial 
resistance, or of genetic determinants, given the amount of 
antibiotics used and released to the environmental.15 The 
transmission of enterococci occurs in the hospital environ-
ment through contact with objects or the hands of health-
care personnel, whereas in the community the main via of 
transmission is the consumption of contaminated water or 
food.5
The objective of this study was to compare the prevalence 
and the characteristics of the strains of VRE isolated from a 
hospital effluent and from municipal wastewater.
MATERIALS AND METHODS
Sample collection
Thirty samples of effluent were obtained from the Hospital 
Universitario José de San Martín (Buenos Aires), at a point 
before the mixture of their waste with municipal wastewa-
ter. This high-level hospital releases approximately 560 m3 
per day to the municipal sewage system.21 All the samples 
of hospital effluent were integrated, through the mixture of 
four aliquots of three liters (12 liters), between 9 a.m. and 3 
p.m., then kept at 4ºC until their processing that same day. 
In parallel, 20 samples of municipal wastewater of the city 
of Buenos Aires were taken from one of the general collec-
tors.
Determination of vancomycin-resistant enterococci
For the counts of enterococci, we diluted the samples and 
spread plate them on Slanetz-Bartley agar with and with-
out vancomycin (6 μgmL-1) (Merk, Germany). After incuba-
tion during 48 h at 37°C, characteristic enterococci colonies 
were selected. When the counts were low, the sample was 
concentrated by filtering through a 0.45 μm membrane 
(Millipore, U.S). The characteristic colonies were subjected 
to assays of catalase, bile esculin, and PYR (pyrrolidone ar-
ylamidase). Identification was carried out by means of the 
API 20 Strep system (Biomerieux, France).
Resistance to antibiotics
The study of susceptibility to antibiotics was performed 
following the Standard for Antimicrobial Susceptibility 
Testing.8The minimum inhibitory concentration (MIC) of 
the VRE was determined by the agar dilution method (se-
rial 2-fold dilutions), for the antibiotics vancomycin (Va) 
and ampicillin (Ap). The MIC was defined as the least con-
centration of antibiotic inhibiting visible growth of the bac-
teria. The positive control used was E. faecium ATCC 19434. 
Resistance to erythromycin 15 μg (Em), teicoplanin 30 μg 
(Tp), gentamicin 120 μg (Gm), and tetracycline 30 μg (Tc) 
(Oxoid, U.K) was determined by the antibiotic disc diffu-
sion method and interpreted according to CLSI criteria.7,10
Statistic analysis
Statistical analyses of the data were performed using the 
software package IBM SPSS Statistics version 20 (IBM 
Corp., New York, U.S).
RESULTS
In our study, although enterococci were detected in the 
samples from both sources, VRE were found in 30% of 
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the samples from the hospital effl uent and in 75% of the 
samples of municipal wastewater. The total counts of en-
terococci in the urban wastewater were higher than in the 
hospital effl uent (Table 1), giving signifi cant differences
(p = 0.036). However, the values of VRE were greater in the 
hospital effl uent, showing an odds ratio of 36.4 (95% CI: 
26.0-50.8; p<0.0001).
Table 1. Bacterial counts (CFU/mL) in Slanetz Bartley agar with and without vancomycin (6 µgmL-1) in samples of hospital 
effl uent and municipal wastewater
VRE a nVREb Total c n
Hospital effl uent 1.7 × 102 1.7 × 103 1.9 × 103 35
Municipal wastewater 4.4 × 101 1.6 × 104 1.6 × 104 21
Total 2.1 × 102 1.8 × 104 1.8 × 104 56
aMean value of count in Slanetz Bartley agar with vancomycin (6 µgmL-1)
bMean value of count of enterococci not resistant to vancomycin (nVRE), obtained by means of the difference between the 
mean values of total enterococci and VRE
c Total enterococci, corresponding to the mean value of count in Slanetz Bartley agar without vancomycin
Figure 1. Species of vancomycin-resistant enterococci (VRE) detected in hospital effl uent and municipal wastewater
From the samples with VRE, we selected a number of colo-
nies for further studies regarding proportionality with re-
spect to the VRE count. To these end 32 strains from the 
hospital effl uent and 46 strains of municipal wastewater 
were isolated. Of these, 60 were identifi ed as E. faecium, 2 as 
E. faecalis, 2 as E. avium, and 6 were E. durans (Fig. 1). Both 
sources showed a high prevalence of E. faecium.
All the strains of enterococci detected in the assays with 
vancomycin presented high MIC for vancomycin and am-
picillin (Table 2). Regarding the rest of the antibiotics tested 
(Table 3), all the strains studied proved resistant to erythro-
mycin. The VRE strains resistant to gentamicin had a signif-
icantly higher prevalence in the hospital effl uent (p= 0.008). 
However, the ones resistant to tetracycline and teicoplanin 
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showed no significant differences between the hospital ef-
fluent and the municipal wastewater (p= 0.061 and 0.95, re-
spectively). In the samples of hospital effluent, 25% of VRE 
were resistant to all six antibiotics assayed. In the samples 
of municipal wastewater, only 4% were resistant to the six 
antibiotics, and the most frequent phenotype of resistance 
was Va Ap Em Tp, identified in 32% of cases.
DISCUSSION
The increase in enterococci with multiple antibiotic resist-
ance stands as a clinical-therapeutic challenge not only in 
the U.S. and Europe, but in most of the world, including 
Argentina. Within its genus, Enterococcus faecium is the spe-
cies most often related with the resistance to multiple anti-
biotics, vancomycin among them.6 Marín et al..17described 
the first clinical isolation of E. faecium resistant to vanco-
mycin in the city of Mendoza (Argentina), attributing its 
resistance to the gene vanA.
In a previous study, conducted between 1996 and 2010, a 
total of 1873 isolations of Enterococcus spp. proceeding from 
hospital infections in the Hospital Universitario José de San 
Martín (Buenos Aires) were analyzed.22 The prevalence of 
E. faecium was found to increase from 1.5% in the year 1996 
to 4% in 2010, and over 70% of the isolations of E. faecium in 
hospital infections are resistant to vancomycin, in line with 
our results (Fig. 1), which would explain the high preva-
lence of VRE in the hospital effluent of our study. The cal-
culated odds ratio indicates that the presence of VRE is 36.4 
Table 2. Distribution of the number of resistant strains, according to the minimum inhibitory concentrations (MIC50 - MIC90) 
to ampicillin and vancomycin, of the VRE isolated in municipal wastewater and hospital effluent
Antibiotic Origin MIC50 (µgmL
-1) MIC90 (µgmL
-1) MIC range
Vancomycin Hospital effluent >960 >960 480->960
Municipal waste-
water
>960 >960 480->960
Ampicillin Hospital effluent 240 480 128-960
Municipal waste-
water
>960 >960 128->960
a Hospital effluent: n = 32
b Municipal wastewater: n = 46
Table 3. Distribution of the phenotypes of resistance to antibiotics of the VRE isolated from hospital effluent and municipal 
wastewater
% of detection (n)
Resistance proflilea Hospital effluent Municipal wastewater
Va Ap Em Gm Tp Tc 25.0 (8) 4.3 (2)
Va Ap Em Gm Tp 25.0 (8) 15.2 (7)
Va Ap Em Gm Tc 6.3 (2)
Va Ap Em Tp Tc 6.3 (2) 28.3 (13 )
Va Ap Em Gm 15.6 (5) 15.2 (7)
Va Ap Em Tc 3.1 (1)
Va Ap Em Tp 9.4 (3) 32.6 (15)
Va Ap Em 9.4 (3) 4.3 (2)
aAdopting the recommendations for nomenclature of the phenotypic characteristics of resistance to antibiotics1,9,20: vancomy-
cin, Va; ampicillin, Ap; erythromycin, Em; teichoplanin, Tp;gentamycin, Gm; and tetracycline, Tc.
125Ars Pharm. 2016; 57(3): 121-126
Hospital effluent constitutes a source of vancomycin-resistantenterococci
times greater in the hospital effluent than in the municipal 
wastewater. The increased presence of resistant bacteria in 
hospital effluents and their influence in municipal waste-
waters have been described previously, underlining the 
need to subject hospital effluents to pretreatment.19
Currently, community infections involving VRE have giv-
en rise to environmental diffusion, leading to widespread 
distribution in urban effluents. Most previous studies co-
incide generally with our results. Goldstein et al..12 found 
VRE in the influents of four municipal wastewater treat-
ment plants in the U.S., in mean concentrations that ranged 
between 2.5×103 and 8.6×104 CFU/mL. A study in the city 
of Porto (Portugal), again involving VRE in a hospital efflu-
ent23, arrived at findings in line with ours: the counts of en-
terococci are similar, and the prevalence of VRE was greater 
in the hospital effluent than in the municipal wastewater 
studied. However, our results also show that E. faecium and 
E. durans are the species of VRE isolate from the hospital 
effluent, whereas the these authors found E. faecalis to be 
more frequent.
All research studies to date indicate that the vancomycin 
resistance in enterococci is most often produced by the gene 
vanA, characterized by a high resistance to vancomycin and 
teicoplanin. Beier et al..3 traced 49 of 50 VRE isolates from 
municipal wastewater to vanA. Our results differ, as only 
40.7% of the strains isolated from the hospital effluent, and 
32.6% of those proceeding from municipal wastewater were 
resistant to vancomycin and teicoplanin, implying a lesser 
prevalence of the vanA phenotype. Yet our results coincide 
in that 100% of all the VRE strains isolated were resistant to 
erythromycin, and 34% of those isolated from the munici-
pal wastewater were resistant to tetracycline. These authors 
found 76% of the strains to be resistant to gentamycin, as 
opposed to the 34% of our strains of municipal origin.
It is also important to point out that all our strains were 
ampicillin resistant, possibly due to the presence of 
β-lactamase. As can be seen in table 2, the MIC was, in all 
the strains, much higher than 16 μgmL-1 for ampicillin and 
32 μgmL-1 for vancomycin, the breakpoints established for 
resistance.8 The resistance to β-lactam antibiotics is common 
in VRE strains, as the literature shows. In a South American 
study involving 20 medical centers, with 218 enterococci 
(either E. faecalisor E. faecium), 14% of the enterococci were 
reportedly resistant to vancomycin, the pattern of resist-
ance indicating the gene vanA, and 24.8% were resistant to 
ampicillin and amoxicillin/clavulanate.14
CONCLUSION
In conclusion, strains of VRE are found in both hospital ef-
fluent and urban wastewater, although the greater concen-
tration would be in hospital effluent. All the VRE isolated 
in this study were moreover resistant to ampicillin and 
erythromycin, and the strains of hospital origin presented a 
greater degree of multi-resistance. Hospital effluent consti-
tutes a source of enterococci having multiple resistance to 
antibiotics, presumably from the feces of patients, because 
the rules of biosecurity in medical centers would impede 
other sources of contamination. The multiresistance pat-
terns found in the VRE strains of municipal wastewater 
present a different distribution, but their high frequency 
suggests a selective effect of resistance due to an excessive 
use of antibiotics in the community. Hospital wastewater 
increased the health and environment risk of sewage, con-
tributing to the dissemination of bacteria resistant to bioc-
ides.
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